Stockholm - Delayed Quote SEK

SynAct Pharma AB (SYNACT.ST)

18.26
-0.48
(-2.56%)
At close: May 13 at 5:29:29 PM GMT+2

Research Analysis

Revenue vs. Earnings

Revenue --
Earnings -90.54M

Q4'21

Q2'23

Q3'23

Q4'23

-80M
-60M
-40M
-20M
0
 

Analyst Price Targets

22.00
22.00 Average
18.26 Current
22.00 High

Earnings Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts ----11
Avg. Estimate 00-1.52.5
Low Estimate 00-1.52.5
High Estimate 00-1.52.5
Year Ago EPS -----2.08-1.5

Revenue Estimate

Currency in SEK Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 1111
Avg. Estimate ------258.1M
Low Estimate ------258.1M
High Estimate ------258.1M
Year Ago Sales --------
Sales Growth (year/est) ----0.00%0.00%

EPS Trend

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Current Estimate 00-1.52.5
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days ----1--
Up Last 30 Days ----1--
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
SYNACT.ST ----27.88%266.67%
S&P 500 13.17%3.05%8.05%13.75%

Related Tickers